Post-transcriptional microRNA repression of PMP22 dose in severe Charcot-Marie-Tooth disease type 1
Open Access
- 20 June 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 146 (10) , 4025-4032
Abstract
Copy number variation (CNV) may lead to pathological traits, and Charcot-Marie-Tooth disease type 1A (CMT1A), the commonest inherited peripheral neuropathy, is due to a genomic duplication encompassing the dosage-sensitive PMP22 gene. MicroRNAs act as repressors on post-transcriptional regulation of gene expression and in rodent models of CMT1A, overexpression of one such microRNA (miR-29a) has been shown to reduce the PMP22 transcript and protein level. Here we present genomic and functional evidence, for the first time in a human CNV-associated phenotype, of the 3′ untranslated region (3′-UTR)-mediated role of microRNA repression on gene expression. The proband of the family presented with an early-onset, severe sensorimotor demyelinating neuropathy and harboured a novel de novo deletion in the PMP22 3′-UTR. The deletion is predicted to include the miR-29a seed binding site and transcript analysis of dermal myelinated nerve fibres using a novel platform, revealed a marked increase in PMP22 transcript levels. Functional evidence from Schwann cell lines harbouring the wild-type and mutant 3′-UTR showed significantly increased reporter assay activity in the latter, which was not ameliorated by overexpression of a miR-29a mimic. This shows the importance of miR-29a in regulating PMP22 expression and opens an avenue for therapeutic drug development.Keywords
Funding Information
- Inherited Neuropathy Consortium (U54NS065712)
- British Medical Association
- Medical Research Council UK (MRC MR/S005021/1)
- National Institute of Neurological Disorders and Stroke (U54NS065712, 1UOINS109403-01, R21TR003034)
- Muscular Dystrophy Association (MDA510281)
- Charcot-Marie-Tooth Association
- University College London Hospitals Biomedical Research Centre
- National Institutes of Health (R21 TR003034)
- Waisman Center
- National Institute of Child Health and Human Development (U54 HD090256)
- National Institute of Neurological Disorders and Stroke/National Center for AdvancingTranslational Sciences (U54 NS065712)
This publication has 30 references indexed in Scilit:
- PMP22 expression in dermal nerve myelin from patients with CMT1ABrain, 2009
- Peripheral myelin protein 22 is regulated post‐transcriptionally by miRNA‐29aGlia, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Identification of Dynamically Regulated MicroRNA and mRNA Networks in Developing OligodendrocytesThe Journal of Neuroscience, 2008
- Gene Duplication: A Drive for Phenotypic Diversity and Cause of Human DiseaseAnnual Review of Genomics and Human Genetics, 2007
- Oligonucleotide Microarray Analysis of Genomic Imbalance in Children with Mental RetardationThe American Journal of Human Genetics, 2006
- APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathyNature Genetics, 2005
- Segmental Duplications and Copy-Number Variation in the Human GenomeThe American Journal of Human Genetics, 2005
- Large-Scale Copy Number Polymorphism in the Human GenomeScience, 2004
- Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNAHuman Molecular Genetics, 1996